Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irvin T Garza

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|July 8, 2026
An AAV vector for glial cellsIrvin T Garza, Steven J Gray
Gene Therapy|November 5, 2024
Expression and distribution of rAAV9 intrathecally administered in juvenile to adolescent miceIrvin T Garza, Meghan M Eller, Sydni K Holmes, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Preclinical Development of a Vectorized Artificial miRNA Gene Therapy for TauopathiesIrvin T Garza, Brina Snyder, Sydni K Holmes, et al.
The Journal of Clinical Investigation|February 19, 2026
AAV-mediated gene therapy in a SLC13A5 citrate transporter disorder model rescues epileptic and metabolic phenotypesLauren E Bailey, Raegan M Adams, Morgan K Schackmuth, et al.
Genes|August 26, 2023
SMRT Sequencing Enables High-Throughput Identification of Novel AAVs from Capsid Shuffling and Directed EvolutionWidler Casy, Irvin T Garza, Xin Chen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|July 8, 2026
An AAV vector for glial cellsIrvin T Garza, Steven J Gray
Gene Therapy|November 5, 2024
Expression and distribution of rAAV9 intrathecally administered in juvenile to adolescent miceIrvin T Garza, Meghan M Eller, Sydni K Holmes, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Preclinical Development of a Vectorized Artificial miRNA Gene Therapy for TauopathiesIrvin T Garza, Brina Snyder, Sydni K Holmes, et al.
The Journal of Clinical Investigation|February 19, 2026
AAV-mediated gene therapy in a SLC13A5 citrate transporter disorder model rescues epileptic and metabolic phenotypesLauren E Bailey, Raegan M Adams, Morgan K Schackmuth, et al.
Genes|August 26, 2023
SMRT Sequencing Enables High-Throughput Identification of Novel AAVs from Capsid Shuffling and Directed EvolutionWidler Casy, Irvin T Garza, Xin Chen, et al.
Pageof 1